Article
ATM polymorphisms as risk factors for prostate cancer development.
British journal of cancer - 16 Aug 2004
Angèle S, Falconer A, Edwards S M, Dörk T, Bremer M, Moullan N, Chapot B, Muir K, Houlston R, Norman A R, Bullock S, Hope Q, Meitz J, Dearnaley D, Dowe A, Southgate C, Ardern-Jones A, Easton D F, Eeles R A, Hall J
Abstract excerpt
The risk of prostate cancer is known to be elevated in carriers of germline mutations in BRCA2, and possibly also in carriers of BRCA1 and CHEK2 mutations. These genes are components of the ATM-dependent DNA damage signalling pathways. To evaluate the hypothesis that variants in ATM itself might be associated with prostate cancer risk, we genotyped five ATM variants in DNA from 637 prostate cancer patients and...
Topics
- Adult
- Aged
- Aged, 80 and over
- Ataxia Telangiectasia Mutated Proteins
- Case-Control Studies
- Cell Cycle
- Cell Cycle Proteins
- DNA-Binding Proteins
- Humans
- Male
